Help with healthcare costs for myasthenia gravis
This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. Check your eligibility with our quick and easy tools below. If this fund is open, apply today for an instant approval decision and use your grant funding right away. Learn how TotalAssist helps you.
Eligibility criteria
To be eligible for this fund, you must:
- Have a confirmed diagnosis and are in treatment for myasthenia gravis, or planning to begin treatment in the next 60 days, or have been in treatment in the past 6 months. This includes active surveillance of a condition
- Have government-insured coverage that covers your qualifying expenses
- Have an income at or less than 500% of the Federal Poverty Level, adjusted for your regional Cost of Living Index (COLI). What is this?
- Be a legal resident and receive treatment in the U.S. or a U.S. territory
- Be prescribed a medication or product listed in the approved medications, listed below
Quick eligibility checker
- Treatment
- Insurance
- Income
Approved medications
Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines.
- Anthrasil (Immune Globulin (Human))
- Asceniv (Immune Globulin, Gamma(Igg))
- Astagraf XL (Tacrolimus)
- Atgam (Immune Globulin G)
- Azasan (Azathioprine)
- Azathioprine (Azathioprine)
- Azathioprine Sodium (Azathioprine)
- BabyBIG (Immune Globulin (Human))
- Bivigam (Immune Globulin Intravenous)
- Bkemv (Eculizumab-Aeeb)
- Cellcept (Mycophenolate Mofetil)
- Cequa (Cyclosporine)
- CUVITRU (Immune Globulin (Human))
- Cyclophosphamide (Cyclophosphamide)
- Cyclosporine (Cyclosporine)
- Cyclosporine Modified (Cyclosporine)
- Cytogam (Immune Globulin (Human))
- Envarsus XR (Tacrolimus)
- Epysqli (Eculizumab-Aagh)
- Flebogamma (Immune Globulin G (Igg))
- Frindovyx (Cyclophosphamide)
- GamaSTAN (Immune Globulin G)
- GAMMAGARD (Immune Globulin (Human))
- GAMMAGARD Liquid (Immune Globulin G)
- GAMMAGARD Liquid ERC (Immune Globulin G)
- GAMMAKED (Immune Globulin G)
- Gamunex-C (Immune Globulin G)
- Gengraf (Cyclosporine)
- HepaGam B (Immune Globulin (Human))
- HYPERHEP B (Immune Globulin (Human))
- HYPERRAB (Immune Globulin (Human))
- HyperRAB (Immune Globulin (Human))
- HYPERRHO (Immune Globulin (Human))
- HyperTET (Immune Globulin (Human))
- HYQVIA (Immune Globulin Intravenous (Human) / Hyaluronidase)
- Imuran (Azathioprine)
- KEDRAB (Immune Globulin (Human))
- Methotrexate-Nacl (Methotrexate Sodium)
- Methotrexate Sodium (Methotrexate Sodium)
- Mycophenolate Mofetil (Mycophenolate Mofetil)
- Myhibbin (Mycophenolate Mofetil)
- Nabi-HB (Immune Globulin (Human))
- Neoral (Cyclosporine)
- North American Coral Snake Antivenin (Equine) (Immune Globulin G)
- Octagam Immune Globulin (Human) (Immune Globulin (Human))
- Panzyga (Immune Globulin (Human))
- Prednisone (Prednisone)
- Prednisone Intensol (Prednisone)
- Prograf (Tacrolimus)
- Pyridostigmine Bromide (Pyridostigmine Bromide)
- Pyridostigmine Bromide Er (Pyridostigmine Bromide)
- Qivigy (Immune Globulin Intravenous)
- Restasis (Cyclosporine)
- Restasis Multidose (Cyclosporine)
- RhoGAM Ultra-Filtered PLUS (Immune Globulin (Human))
- Rhophylac (Immune Globulin (Human))
- Riabni (Rituximab-Arrx)
- Rituxan (Rituximab)
- Ruxience (Rituximab-Pvvr)
- Rystiggo (Rozanolixizumab-Noli)
- Sandimmune (Cyclosporine)
- Soliris (Eculizumab)
- Tacrolimus (Tacrolimus)
- Thymoglobulin (Immune Globulin, Gamma(Igg))
- Truxima (Rituximab-Abbs)
- Ultomiris (Ravulizumab-Cwvz)
- VARIZIG (Immune Globulin (Human))
- Vyvgart (Efgartigimod Alfa-Fcab)
- VYVGART Hytrulo (Efgartigimod-Hyaluronidas-Qvfc)
- WinRho SDF (Immune Globulin (Human))
- XEMBIFY (Immune Globulin, Gamma(Igg) Klhw)
- YIMMUGO (Immune Globulin, Gamma(Igg) Dira)
- Zilbrysq (Zilucoplan Sodium)
About the disease
Myasthenia Gravis (MG) is a disorder that causes weakness in the skeletal muscles that the body uses for movement. It is a rare disorder that affects the musculoskeletal and nervous systems. Subtypes include congenital myasthenia gravis, generalized myasthenia gravis, ocular myasthenia gravis, transient neonatal myasthenia gravis, and juvenile myasthenia gravis.
Diagnosis codes
G70.00, G70.01
How to apply
-
If your fund is open, apply online 24/7, or call 866-512-3861, Monday – Friday, 8:30am – 5:30pm ET.
-
Answer pre-screening questions to confirm eligibility. Have your income, medication, diagnosis, and insurance information ready.
-
Complete the application and get an instant approval decision. You can begin using your grant right away.
Application guides
Questions?
Search help articles
Find answers to your questions about applying, claims, grant use, and your portal account.
Search help
How does it work?
You can use your TotalAssist grant award to help pay for out-of-pocket healthcare expenses.
Learn more
Need help applying?
Call us at 866-512-3861 to apply by phone, Monday through Friday, 8:30am - 5:30pm ET.
Contact usRelated organizations
Connect with other organizations and resources for support.
Featured partner:
The Myasthenia Gravis Foundation of America (MGFA) provides education, support, and resources to help individuals and families navigate life with myasthenia gravis. Through patient programs, support groups, educational events, and trusted information, MGFA helps people connect with others, better understand their diagnosis, and make informed care decisions. MGFA also advances research and advocates for improved treatments and care.
Get support
Explore resources beyond TotalAssist
Patient Advocate Foundation knows that patients may need support, information, and resources beyond TotalAssist. This can include services like case management, help with living expenses, and much more. Search our National Financial Resources Directory, find community specific resources, and explore our patient education library.
Find resources